There were 1,725 press releases posted in the last 24 hours and 439,317 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Portola Pharmaceuticals Announces Phase 3 ANNEXA™-R Part 2 Study Results to be Presented at American Heart Association Scientific Sessions 2015

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image